List of Keppra drug patents

Keppra is owned by Ucb Inc.

Keppra contains Levetiracetam.

Keppra has a total of 2 drug patents out of which 0 drug patents have expired.

Keppra was authorised for market use on 30 November, 1999.

Keppra is available in tablet;oral dosage forms.

The generics of Keppra are possible to be released after 07 December, 2031.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8802142 UCB INC Pharmaceutical compositions comprising levetiracetam and process for their preparation
Jun, 2031

(8 years from now)

US8802142

(Pediatric)

UCB INC Pharmaceutical compositions comprising levetiracetam and process for their preparation
Dec, 2031

(8 years from now)

Drugs and Companies using LEVETIRACETAM ingredient

Market Authorisation Date: 30 November, 1999

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of KEPPRA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in